相似文献
1
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.
Drug Discov Today. 2017 Apr;22(4):665-680. doi: 10.1016/j.drudis.2016.12.009. Epub 2016 Dec 23.
2
Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
Curr Top Med Chem. 2021;21(2):126-139. doi: 10.2174/1568026620666200922113846.
3
Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Pharm Res. 2014 Apr;31(4):1032-45. doi: 10.1007/s11095-013-1225-y. Epub 2013 Oct 24.
4
Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Daru. 2021 Dec;29(2):439-447. doi: 10.1007/s40199-021-00416-6. Epub 2021 Sep 9.
5
Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid.
Int J Nanomedicine. 2019 Jun 27;14:4649-4666. doi: 10.2147/IJN.S201110. eCollection 2019.
6
Advances in Hyaluronic Acid-Based Drug Delivery Systems.
Curr Drug Targets. 2016;17(6):720-30. doi: 10.2174/1389450116666150531155200.
7
Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Biomaterials. 2011 Oct;32(29):7181-90. doi: 10.1016/j.biomaterials.2011.06.028. Epub 2011 Jul 5.
8
GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Int J Nanomedicine. 2016 Oct 7;11:5125-5147. doi: 10.2147/IJN.S113469. eCollection 2016.
9
Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Pharm Res. 2014 Nov;31(11):2988-3005. doi: 10.1007/s11095-014-1393-4. Epub 2014 May 20.
10
CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
Mol Pharm. 2016 Dec 5;13(12):4209-4221. doi: 10.1021/acs.molpharmaceut.6b00870. Epub 2016 Oct 31.
引用本文的文献
1
Prospects and Challenges of Different Delivery Systems in Breast Tumors Therapy.
Breast Cancer (Auckl). 2025 Aug 15;19:11782234251365941. doi: 10.1177/11782234251365941. eCollection 2025.
2
Recent Progress of Polymer-Based Biosensors for Cancer Diagnostic Applications: Natural versus Synthetic Polymers.
ACS Omega. 2025 Mar 3;10(9):8816-8831. doi: 10.1021/acsomega.4c10652. eCollection 2025 Mar 11.
3
Facile One-Pot Preparation of Self-Assembled Hyaluronate/Doxorubicin Nanoaggregates for Cancer Therapy.
Biomimetics (Basel). 2025 Feb 6;10(2):91. doi: 10.3390/biomimetics10020091.
4
Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer.
Cell Mol Biol Lett. 2024 Aug 28;29(1):113. doi: 10.1186/s11658-024-00623-4.
5
Transforming Healthcare with Nanomedicine: A SWOT Analysis of Drug Delivery Innovation.
Drug Des Devel Ther. 2024 Aug 5;18:3499-3521. doi: 10.2147/DDDT.S470210. eCollection 2024.
6
Exploring the Formulation and Approaches of Injectable Hydrogels Utilizing Hyaluronic Acid in Biomedical Uses.
Adv Pharmacol Pharm Sci. 2024 May 27;2024:3869387. doi: 10.1155/2024/3869387. eCollection 2024.
7
Polymer-Based Drug Delivery Systems for Cancer Therapeutics.
Polymers (Basel). 2024 Mar 19;16(6):843. doi: 10.3390/polym16060843.
8
Selective enhanced cytotoxicity of amino acid deprivation for cancer therapy using thermozyme functionalized nanocatalyst.
J Nanobiotechnology. 2024 Feb 7;22(1):53. doi: 10.1186/s12951-024-02326-6.
9
Potent Suppression of Prostate Cancer Cell Growth and Eradication of Cancer Stem Cells by CD44-targeted Nanoliposome-quercetin Nanoparticles.
J Cancer Prev. 2023 Dec 30;28(4):160-174. doi: 10.15430/JCP.2023.28.4.160.
10
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.
Mol Cancer. 2023 Oct 3;22(1):160. doi: 10.1186/s12943-023-01849-0.
本文引用的文献
1
Bioconjugation Using Thiols: Old Chemistry Rediscovered to Connect Polymers with Nature's Building Blocks.
ACS Macro Lett. 2013 Jan 15;2(1):14-18. doi: 10.1021/mz3005814. Epub 2012 Dec 14.
2
Phototheranostics of CD44-positive cell populations in triple negative breast cancer.
Sci Rep. 2016 Jun 15;6:27871. doi: 10.1038/srep27871.
3
CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.
Obstet Gynecol. 2016 Jun;127(6):1003-1011. doi: 10.1097/AOG.0000000000001420.
4
Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality.
Urol Oncol. 2016 Aug;34(8):337.e19-26. doi: 10.1016/j.urolonc.2016.03.015. Epub 2016 Apr 26.
5
pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin.
Int J Mol Sci. 2016 Mar 30;17(4):364. doi: 10.3390/ijms17040364.
6
Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake.
Colloids Surf B Biointerfaces. 2016 Jul 1;143:27-36. doi: 10.1016/j.colsurfb.2016.03.019. Epub 2016 Mar 9.
7
Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer.
Front Immunol. 2016 Feb 8;7:39. doi: 10.3389/fimmu.2016.00039. eCollection 2016.
8
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis.
Onco Targets Ther. 2016 Jan 21;9:431-44. doi: 10.2147/OTT.S97192. eCollection 2016.
9
Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Biomaterials. 2016 Apr;84:250-261. doi: 10.1016/j.biomaterials.2016.01.049. Epub 2016 Jan 23.
10
Mixed Micelles for Targeted and Efficient Doxorubicin Delivery to Multidrug-Resistant Breast Cancer Cells.
Macromol Biosci. 2016 May;16(5):748-58. doi: 10.1002/mabi.201500381. Epub 2016 Jan 25.
Zotero 插件